First Turn Management, LLC Rocket Pharmaceuticals, Inc. Transaction History

First Turn Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$17.6 - $25.88 $1.06 Million - $1.56 Million	60,317 Added 10.75%	621,306 $11.5 Billion
Q2 2024 Aug 07, 2024	BUY	$20.66 - $26.72 $6.41 Million - $8.29 Million	310,119 Added 123.62%	560,989 $12.1 Billion
Q1 2024 May 03, 2024	BUY	$26.16 - $30.74 $6.56 Million - $7.71 Million	250,870 New	250,870 $6.76 Billion

244

108M

262K

159K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $630M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of First Turn Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Turn Management, LLC with notifications on news.